Lutropin (LH) plays a critical role in gonadal development and gametogenesis, and the production of the sex steroids such as estradiol (E2); its physiological regulation is thus important for normal fertility. LH consists of the alpha-subunit common to all pituitary glycoprotein hormones, and a unique LHBeta subunit which is regulated by E2 in both a positive and negative manner in vivo. We have shown that the rat LH-beta gene can be directly stimulated by E2 via an estrogen response element (ERE) to a degree which is modulated by estrous cycle stage of pitUitary tissue, and by the hypothalamiC peptide GnRH. We have recently identified and cloned a smaller form of rat estrogen receptor (ER) mRNA which is detected only in the pituitary and only in females. The pituitary-specific ER mRNA has a N-terminal truncated coding sequence, and a unique 5 prime sequence, and is dramatically stimulated by E2. An ER protein of the appropriate translation product size is present in female pituitaries. We have also isolated additional cDNAs encoding ER mRNA splice variants and isoforms which do not exhibit such dramatic specificity and which contain the DNA binding domain. Our goal is to determine the biological activity and physiological regulation of the pituitary-specific ERs. Cloned cDNAs will be characterized by sequencing and mRNA by primer extension analysis, and for tissue expression. Levels of pituitary-specific and variant ER mRNA and protein will be quantitated throughout the estrous cycle, and after treatment of female rats with progesterone and estrogen. The level of wild type and variant ER protein expression will be determined by Western blotting of pituitary extracts followed by detection of protein with -domain-specific ER antibodies, or by immunoprecipitation. Variant ER mRNA transcripts will be localized to specific pituitary cell types by in situ hybridization. Variant ER protein will be tested for its ability to bind E2 and DNA, including EREs for the vitellogenin, LHBeta and prolactin genes, and to form homodimers or heterodimers with the wild type ER. The ability of variant ER to stimulate gene activity alone, or to influence the ability of wild type ER to do so will be evaluated in transient expression assays in Cos or 293 cells cotransfected with expression vectors for variant and wild type ER at several ratios. Secretion and gene activation responses will be measured in cotransfection studies in GH3 cells. These experiments will determine if variant ER expression could influence tissue responses to E2 and if this occurs in a promoter- specific manner. Variations in amounts of ER proteins-with different biological activities or specificities could have profound physiological implications, and thus contribute to the numerous biological changes during the reproductive cycle, such as the initiation and limitation of the proestrus surge.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD025719-09
Application #
2673589
Study Section
Endocrinology Study Section (END)
Project Start
1989-06-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Resnick, E M; Schreihofer, D A; Periasamy, A et al. (2000) Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors alpha and beta. J Biol Chem 275:7158-66
Weck, J; Anderson, A C; Jenkins, S et al. (2000) Divergent and composite gonadotropin-releasing hormone-responsive elements in the rat luteinizing hormone subunit genes. Mol Endocrinol 14:472-85
Schreihofer, D A; Resnick, E M; Soh, A Y et al. (1999) Transcriptional regulation by a naturally occurring truncated rat estrogen receptor (ER), truncated ER product-1 (TERP-1). Mol Endocrinol 13:320-9
Murphy, A Z; Shupnik, M A; Hoffman, G E (1999) Androgen and estrogen (alpha) receptor distribution in the periaqueductal gray of the male Rat. Horm Behav 36:98-108
Jazaeri, O; Shupnik, M A; Jazaeri, A A et al. (1999) Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma. Gynecol Oncol 74:38-47
Jeng, M H; Shupnik, M A; Bender, T P et al. (1998) Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139:4164-74
Shupnik, M A; Pitt, L K; Soh, A Y et al. (1998) Selective expression of estrogen receptor alpha and beta isoforms in human pituitary tumors. J Clin Endocrinol Metab 83:3965-72
Weck, J; Fallest, P C; Pitt, L K et al. (1998) Differential gonadotropin-releasing hormone stimulation of rat luteinizing hormone subunit gene transcription by calcium influx and mitogen-activated protein kinase-signaling pathways. Mol Endocrinol 12:451-7
Friend, K E; Resnick, E M; Ang, L W et al. (1997) Specific modulation of estrogen receptor mRNA isoforms in rat pituitary throughout the estrous cycle and in response to steroid hormones. Mol Cell Endocrinol 131:147-55
Rice, L W; Jazaeri, A A; Shupnik, M A (1997) Estrogen receptor mRNA splice variants in pre- and postmenopausal human endometrium and endometrial carcinoma. Gynecol Oncol 65:149-57

Showing the most recent 10 out of 19 publications